Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.700
+0.130 (8.28%)
Nov 24, 2025, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $102.97 million as of November 25, 2025. Its market cap has decreased by -45.93% in one year.
Market Cap
102.97M
Enterprise Value
-2.24M
1-Year Change
-45.93%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $102.97M, a decrease of -83.35%. That is a compound annual growth rate of -33.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 102.97M | -0.35% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |